These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 35982542)
1. Gold Nanocage-Based Photothermal Ablation Facilitates In Situ Vaccination for Melanoma Therapy. Zhang M; Chen Y; Li D; He Z; Wang H; Wu A; Fei W; Zheng C; Liu E; Huang Y ACS Appl Mater Interfaces; 2022 Aug; 14(34):38550-38561. PubMed ID: 35982542 [TBL] [Abstract][Full Text] [Related]
2. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy. Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821 [TBL] [Abstract][Full Text] [Related]
3. Photothermally sensitive gold nanocage augments the antitumor efficiency of immune checkpoint blockade in immune "cold" tumors. Xiao G; Zhao Y; Wang X; Zeng C; Luo F; Jing J Front Immunol; 2023; 14():1279221. PubMed ID: 37942337 [TBL] [Abstract][Full Text] [Related]
4. Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment. Tsukamoto H; Fujieda K; Miyashita A; Fukushima S; Ikeda T; Kubo Y; Senju S; Ihn H; Nishimura Y; Oshiumi H Cancer Res; 2018 Sep; 78(17):5011-5022. PubMed ID: 29967259 [TBL] [Abstract][Full Text] [Related]
5. Reprogramming the Tumor Microenvironment through Second-Near-Infrared-Window Photothermal Genome Editing of PD-L1 Mediated by Supramolecular Gold Nanorods for Enhanced Cancer Immunotherapy. Tang H; Xu X; Chen Y; Xin H; Wan T; Li B; Pan H; Li D; Ping Y Adv Mater; 2021 Mar; 33(12):e2006003. PubMed ID: 33538047 [TBL] [Abstract][Full Text] [Related]
6. Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors. Zhang M; Wang L; Liu W; Wang T; De Sanctis F; Zhu L; Zhang G; Cheng J; Cao Q; Zhou J; Tagliabue A; Bronte V; Yan D; Wan X; Yu G J Immunol Res; 2022; 2022():2253436. PubMed ID: 35785030 [TBL] [Abstract][Full Text] [Related]
7. Ultra-thin layered double hydroxide-mediated photothermal therapy combine with asynchronous blockade of PD-L1 and NR2F6 inhibit hepatocellular carcinoma. Lu YF; Zhou JP; Zhou QM; Yang XY; Wang XJ; Yu JN; Zhang JG; Du YZ; Yu RS J Nanobiotechnology; 2022 Jul; 20(1):351. PubMed ID: 35907841 [TBL] [Abstract][Full Text] [Related]
8. A TLR3-Specific Adjuvant Relieves Innate Resistance to PD-L1 Blockade without Cytokine Toxicity in Tumor Vaccine Immunotherapy. Takeda Y; Kataoka K; Yamagishi J; Ogawa S; Seya T; Matsumoto M Cell Rep; 2017 May; 19(9):1874-1887. PubMed ID: 28564605 [TBL] [Abstract][Full Text] [Related]
9. DTX@VTX NPs synergy PD-L1 immune checkpoint nanoinhibitor to reshape immunosuppressive tumor microenvironment for enhancing chemo-immunotherapy. Zhang R; Wan Y; Lv H; Li F; Lee CS J Mater Chem B; 2021 Sep; 9(36):7544-7556. PubMed ID: 34551052 [TBL] [Abstract][Full Text] [Related]
10. Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence. Li M; Guo R; Wei J; Deng M; Li J; Tao Y; Li M; He Q Acta Biomater; 2021 Dec; 136():546-557. PubMed ID: 34536603 [TBL] [Abstract][Full Text] [Related]
11. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade. Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365 [TBL] [Abstract][Full Text] [Related]
12. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis. Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026 [TBL] [Abstract][Full Text] [Related]
13. Rationally designed peptide-conjugated gold/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy. Yang Q; Peng J; Shi K; Xiao Y; Liu Q; Han R; Wei X; Qian Z J Control Release; 2019 Aug; 308():29-43. PubMed ID: 31252039 [TBL] [Abstract][Full Text] [Related]
14. Photothermal therapy mediated by gold nanocages composed of anti-PDL1 and galunisertib for improved synergistic immunotherapy in colorectal cancer. Wang S; Song Y; Cao K; Zhang L; Fang X; Chen F; Feng S; Yan F Acta Biomater; 2021 Oct; 134():621-632. PubMed ID: 34329782 [TBL] [Abstract][Full Text] [Related]
15. eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma. Chen X; Wang K; Jiang S; Sun H; Che X; Zhang M; He J; Wen Y; Liao M; Li X; Zhou X; Song J; Ren X; Yi W; Yang J; Chen X; Yin M; Cheng Y J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35347072 [TBL] [Abstract][Full Text] [Related]
16. In Situ Vaccination with An Injectable Nucleic Acid Hydrogel for Synergistic Cancer Immunotherapy. Wang F; Xie M; Huang Y; Liu Y; Liu X; Zhu L; Zhu X; Guo Y; Zhang C Angew Chem Int Ed Engl; 2024 Jan; 63(4):e202315282. PubMed ID: 38032360 [TBL] [Abstract][Full Text] [Related]
17. Ag nanoparticles enhance immune checkpoint blockade efficacy by promoting of immune surveillance in melanoma. Kuang X; Wang Z; Luo Z; He Z; Liang L; Gao Q; Li Y; Xia K; Xie Z; Chang R; Wang Y; Liu Y; Zhao S; Su J; Wang Y; Situ W; Chen M; Zhao Y; Chen X; Xie H; Liu H J Colloid Interface Sci; 2022 Jun; 616():189-200. PubMed ID: 35203032 [TBL] [Abstract][Full Text] [Related]
18. Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response. Liang R; Xie J; Li J; Wang K; Liu L; Gao Y; Hussain M; Shen G; Zhu J; Tao J Biomaterials; 2017 Dec; 149():41-50. PubMed ID: 28992509 [TBL] [Abstract][Full Text] [Related]
19. Phytochemical-derived tumor-associated macrophage remodeling strategy using Phoenix dactylifera L. boosted photodynamic therapy in melanoma via H19/iNOS/PD-L1 axis. Soliman AH; Youness RA; Sebak AA; Handoussa H Photodiagnosis Photodyn Ther; 2023 Dec; 44():103792. PubMed ID: 37689125 [TBL] [Abstract][Full Text] [Related]
20. Case Report: Huang JW; Kuo CL; Wang LT; Ma KS; Huang WY; Liu FC; Yang KD; Yang BH Front Immunol; 2021; 12():752563. PubMed ID: 35003064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]